Mexico signed agreements with three companies on Tuesday that are developing vaccines against Covid-19, and it expects to secure doses for more than 100 million people through 2021.
Mexico will buy eventual vaccines for 39 million people from AstraZeneca, as many as 17 million from Pfizer Inc. and 35 million from China´s CanSino Biologics Inc.
It´s also participating in the international vaccine alliance Covax, through which it expects to obtain doses for about 26 million people.
With a population of 126 million, Mexico is among the countries with the most deaths of people infected with the SARS-CoV-2 virus with close to 84,000, according to health officials.
Mexico will participate within days in the phase 3 clinical trials being carried out by CanSino, and is in talks with companies from the U.S., Germany, Russia, France and Italy, Foreign Minister Marcelo Ebrad said.